Company: NAYA Biosciences
Ticker: Nasdaq: NAYA
Sector: Healthcare
Investor Contact: Robert Blum

NAYA Biosciences News

News

INVO Bioscience Reports Third Quarter 2020 Financial Results

Company to Provide Investor Update on November 19 at 4:30pm ET (Details Below)SARASOTA, Fla., Nov. 16, 2020 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and...

INVO Bioscience Reports Second Quarter 2020 Financial Results

Company to Provide Investor Update During Virtual Investor Conference on August 19 at 2:00pm ET (Details Below); Management Available for Virtual 1x1 MeetingsSARASOTA, Fla., Aug. 13, 2020 -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on...

INVO Bioscience Receives Registration Approval for INVOcell in Turkey

- An estimated 15% to 20% of the Turkish population suffers from the difficulty of conceiving- "As the world's only Intravaginal Culture System, INVOcell, a streamlined treatment solution, is uniquely positioned to address the challenges within the infertility...

INVO Bioscience Announces Closing of Financing

SARASOTA, Fla., June 29, 2020 -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System,...

Skip to content